News

Curry recall in 33 states as FDA issues risk warning

Jagpreet Enterprises LLC issued a voluntary recall for four products on July 23 due to potential metal contamination.

The FDA Let Substandard Factories Ship These Medications to the U.S.

ProPublica identified more than 150 products that were exempted from import bans since 2013. Our list provides the names of ...

A Giant Indian Drugmaker Failed to Fix Safety Breaches. The FDA Let It Off the Hook Again and Again.

Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, ...

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...

Ousted FDA vaccine regulator Vinay Prasad returns to post

Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks ...

FDA Approves Ajovy for Migraine Prevention in Children and Teens

By Lori Solomon HealthDay ReporterMONDAY, Aug. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Hand Soap Recalled Nationwide Over Sepsis Concerns, FDA Says

The FDA and DermaRite are recalling hand soap because it could be contaminated with Burkholderia cepecia. Here’s a list of ...

Return of FDA official targeted by Trump allies hits biotech shares

Sarepta shares dropped as much as 5.2 per cent on Monday amid volatile trading, while those of Replimune — another gene ...
Healio22h

Oncologist returns to FDA leadership role 2 weeks after abrupt departure

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

Nationwide Deodorant Recall Update as FDA Sets Risk Level

The recall of three Power Stick deodorants, affecting more than 67,000 products sold across the United States, was voluntary issued by Pennsylvania-based maker A.P. Deauville on July 10. FDA ...
The Boston Globe13h

FDA regulator’s reinstatement sends biotech shares tumbling

Prasad and FDA Commissioner Marty Makary had asked Sarepta to cease shipping its treatment for Duchenne muscular dystrophy. At the FDA, Prasad will resume his role as head of CBER, but it’s unclear ...